
A new antidepressant is expected to soon be approved by the Food and Drug Administration.
The New York Times reported yesterday that an advisory panel at the agency has voted in favor of recommending approval of the new drug, the nasal spray Esketamine, to treat severely depressed patients.
Click here to read the full article…

Seated Left to Right: Jeff Lima, Kelly Lennon-Martucci, Louisa Benton, and Hope Kronman
Standing: Daniel Lampert and Aidan Golub, Student Organizers
Hope for Depression Research Foundation was proud to conduct an expert panel on “Bullying and Mental Health” at the Open Minds summit held January 10 at the Solomon Schechter High School in Westchester, NY.
Click here to read the full article…

February! As we move into the second month of the year, we are thinking about how quickly time can pass. For many, the start of a new year is a time to reflect on time itself and, of course, our own years of life.
Though growing old is a natural process that we all know to expect, it is important to be aware of common mental health risks that can come with advancing age.
Click here to read the full article…

Co-Grand Marshals Scott Snyder and Audrey Gruss cut the starting tape
Mother Nature tried but failed to deter hundreds of intrepid souls who came out in pouring rain and hurricane wind for the Hope for Depression Research Foundation’s (HDRF) Inaugural Palm Beach Race of Hope 5K on Sunday, January 27, 2019.
Click here to read the full article…

As winter approaches many of us may begin to feel the “winter blues.” Perhaps we will sleep in more, feel more lethargic in our day to day, notice an increased appetite, or even withdraw socially.*
Because of how common these symptoms are in the winter and fall, it can be easy to overlook them, but for some people colder darker seasons bring an onset of a specific type of depression called Seasonal Affective Disorder.
Click here to read the full article…